Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department? - Full Text View

Does Implementing a Urinanylsis Protocol Based on Symptoms Decrease Length of Stay in the Emergency Department?

This study is not yet open for participant recruitment.
Verified by University of California, Los Angeles, December 2007

Sponsored by:	University of California, Los Angeles
Information provided by:	University of California, Los Angeles
ClinicalTrials.gov Identifier:	NCT00583648

Purpose

The implementation of nursing urinanlysis protocols based off of symptoms of urinary infections will significantly decrease the length of a patient's stay in the Emergency Department.

Condition	Intervention
Urinary Tract Infections	Other: Urinanlysis

MedlinePlus related topics:

Urinary Tract Infections

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Other, Randomized, Open Label, Single Group Assignment

Official Title:	A Randomized Controlled Trial Showing the Effect of Patient Lenght of Stay in the Emergency Department Through Utilizing a Urinalysis Nursing Protocol.

Further study details as provided by University of California, Los Angeles:

Primary Outcome Measures:

Length of Stay in the Emergency Department [ Time Frame: 1 hour ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Physician decision making on ordering urinalysis based off of chief complaints [ Time Frame: 1 hour ] [ Designated as safety issue: No ]

Estimated Enrollment:	150
Study Start Date:	February 2008
Estimated Study Completion Date:	February 2009

Arms	Assigned Interventions
1: Experimental Recieves urinalysis by nurse per set protocol based off of inclusion criteria	Other: Urinanlysis sending a Urine sample to the laboratory for processing
2: No Intervention ordering of test will be up to the treating physician

Eligibility

Ages Eligible for Study:	16 Years to 65 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

patients between 16 and 65 years of age complaining of any of the following: dysuria, hematuria, urinary frequency, urinary urgency

Exclusion Criteria:

any person less than 16 or greater than 65 years of age, history of kidney disease or transplant, foley catherization within the last 30 days, on immuno-suppresent and/or receiving chemotherapy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00583648

Contacts


Contact: Andrew W Seefeld, M.D.	310-825-2112	aseefeld@mednet.ucla.edu

Contact: David Schriger, M.D., M.P.H.	310-794-0593	dschriger@ucla.edu

Locations


United States, California
	University of California, Los Angeles Medical Center
	Los Angeles, California, United States, 90095

Sponsors and Collaborators

University of California, Los Angeles

Investigators


Principal Investigator:	Andrew W Seefeld, M.D.	University of California, Los Angeles

More Information

Responsible Party:	University of California, Los Angeles, Department of Emergency Medicine ( Dr. David Schriger, M.D., M.P.H. )
Study ID Numbers:	UCLA-urineprotocol, UCLA-12345
First Received:	December 20, 2007
Last Updated:	December 20, 2007
ClinicalTrials.gov Identifier:	NCT00583648
Health Authority:	United States: Institutional Review Board